Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. Though the exact cause of growth hormone deficiency is obscure, it is considered to be of genetic origin or also it can develop after a trauma, brain injury, due to pituitary tumors etc. Children with growth hormone deficiency show retarded growth and sometimes delayed puberty. Symptoms of growth hormone deficiency vary among adults and children. The predominant symptom in children is that the child is abnormally shorter than other children of his age with or without compromise in the cognitive intelligence while in adults, growth hormone deficiency may lead to fatigue, tiredness, anxiety and depression. Growth hormone deficiency is treated with growth hormone injections on daily or weekly basis although the effects of therapy starts showing after 2-3 months of therapy.
The primary factor contributing to the growth of global growth hormone deficiency treatment market is increasing incidence of growth hormone deficiency syndrome. Several other factors which may cause the global growth hormone deficiency market to grow include changing lifestyle, prevalence of other genetic disorders and incidence of GHD in adults. However, high cost of treatment will always remain the major restraint for global growth hormone deficiency treatment market.
For detailed insights on enhancing your product footprint, request for a Sample here @ https://www.persistencemarketresearch.co/samples/9962
The global growth hormone deficiency treatment market has been segmented on the basis of treatment type, end user, retail sales channels and geography.
Based on treatment type, the global hyperpigmentation treatment market is divided into following:
- Pharmacological therapy
- Recombinant Human Growth Hormone
- Human pituitary gland extracts
Based on end user, the global hyperpigmentation treatment market is divided into following:
- Home care settings
Based on retail sales channels, the global hyperpigmentation treatment market is divided into following:
- Pharmacy and drugstores
- Hospital pharmacy
- Online drug stores/email prescription stores
Surgeries in treatment of growth hormone deficiency treatment are rarely performed. Recombinant human growth hormone sub-segment of pharmacological therapy treatment type is expected to hold major share in the global growth hormone deficiency treatment market due to increased patient compliance. Home care settings’ end user segment occupies significant proportion of global growth hormone deficiency treatment market owing to the nature of a therapy requiring daily dosage administration. Introduction of new medicines such as Saizen solution is anticipated to expand the market growth of global growth hormone deficiency treatment market over the forecast period of 2016-2026.
For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/9962
Geographically, the global growth hormone deficiency treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to contribute largest market share in global growth hormone deficiency treatment market followed by Europe. Emerging markets such as China, India, and Brazil are expected to present good opportunity for growth hormone deficiency treatment market due to entrance of key players into the market.
Some of the major players in the global growth hormone deficiency treatment market include:
- Sandoz International GmbH
- Sanofi Aventis
- Novo Nordisk A/S
- Teva Pharmaceutical Industries Limited
- EMD Serono
- Sun Pharmaceutical Industries Ltd.
- Eli Lilly and Company
Explore Extensive Coverage of Persistence Market Research`s Healthcare Landscape
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]